Molecular Mechanisms in Heart Failure and Inflammageing
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 135
Special Issue Editor
2. Division of Cardiology, Department of Medicine, School of Medicine, The Chinese University of Hong Kong, Shenzhen, China
3. School of Public Health, St Mary's Campus, Faculty of Medicine, Imperial College London, London, UK
Interests: heart failure and inflammageing; thrombosis; circulation research
Special Issue Information
Dear Colleagues,
Heart failure (HF) is one of the leading causes of hospital admission and mortality, affecting at least 26 million people worldwide. In HF pathology, there is a consistent increase in the number of cytokines and chemokines that are hallmarks of chronic inflammation and kidney dysfunction. Thus, inflammation is one of the most critical causes in HF. Despite extensive studies, the molecular pathways involved in heart failure-associated inflammageing are still not completely understood. This Special Issue aims to gather accurate and up-to-date scientific information which will further strengthen our knowledge about inflammation and HF. We are pleased to invite you and your co-workers to submit your original research and comprehensive review articles that focus on (but are not limited to) the following:
- The chemokine and molecular aspects of HF, including the pathophysiological mechanisms;
- The pharmacological interventions to prevent and ameliorate HF;
- The recent advances in understanding the overall molecular mechanism in HF and inflammageing.
Dr. Erik Fung
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- inflammaging
- cardiomyopathies
- cardiology
- chemokines
- cytokines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
